Lin BioScience Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	11,908	1,488	3,261	1,645	806.85
Short-Term Investments	4,384	3,571	-	-	-
Trading Asset Securities	-	149.14	-	-	-
Cash & Short-Term Investments	16,293	5,208	3,261	1,645	806.85
Cash Growth	212.82%	59.71%	98.21%	103.91%	-26.13%
Other Receivables	23.33	19.37	25.47	0.11	1.49
Receivables	23.33	19.37	25.47	0.11	1.49
Prepaid Expenses	139.93	123.27	137.69	-	-
Other Current Assets	0.16	0.35	0	27.01	11.21
Total Current Assets	16,456	5,351	3,424	1,672	819.54
Property, Plant & Equipment	37.98	50.66	58.91	65.86	5.4
Long-Term Investments	8,806	-	-	-	-
Other Intangible Assets	113.23	118.4	108.91	108.92	97.12
Other Long-Term Assets	12.96	6.68	4.69	4.94	1.17
Total Assets	25,426	5,527	3,597	1,852	923.23
Accrued Expenses	-	120.82	111.47	59.16	44.94
Current Portion of Leases	14.42	16.1	13.85	10.32	2.24
Other Current Liabilities	268.43	18.4	13.38	10.39	423.07
Total Current Liabilities	282.85	155.33	138.7	79.88	470.25
Long-Term Leases	8.4	17.89	29.03	36.18	-
Total Liabilities	291.24	173.22	167.73	116.06	470.25
Common Stock	828.27	786.3	785.16	723.19	689.9
Additional Paid-In Capital	14,101	4,827	3,477	1,935	1,029
Retained Earnings	-4,269	-2,907	-2,162	-1,475	-1,162
Comprehensive Income & Other	73.26	148.35	37.34	51.55	-15.93
Total Common Equity	10,733	2,855	2,137	1,234	541.57
Minority Interest	14,402	2,499	1,292	501.86	-88.59
Shareholders' Equity	25,134	5,354	3,429	1,736	452.98
Total Liabilities & Equity	25,426	5,527	3,597	1,852	923.23
Total Debt	22.81	33.99	42.87	46.5	2.24
Net Cash (Debt)	16,270	5,174	3,218	1,599	804.61
Net Cash Growth	214.43%	60.78%	101.30%	98.70%	-25.99%
Net Cash Per Share	198.17	65.83	43.50	22.29	11.70
Filing Date Shares Outstanding	82.73	78.63	78.52	72.32	68.99
Total Common Shares Outstanding	82.73	78.63	78.52	72.32	68.99
Working Capital	16,173	5,196	3,286	1,592	349.29
Book Value Per Share	129.73	36.31	27.22	17.07	7.85
Tangible Book Value	10,619	2,737	2,028	1,125	444.45
Tangible Book Value Per Share	128.37	34.80	25.84	15.56	6.44
Machinery	-	21.65	16.64	16.44	6.04
Leasehold Improvements	-	11.05	10.67	10.67	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.